title: Prednisolone and cefapirin act synergistically in resolving experimental Escherichia coli mastitis.
abstract: Mastitis in dairy cows is typically treated with intramammary antibiotics. The combination of antibiotics with corticosteroids tends to have a large market share where these products are registered. Our objective was to investigate the effect of prednisolone in combination with cefapirin on the inflammatory response of experimentally induced Escherichia coli mastitis. Six midlactating Holstein-Friesian cows were challenged in 3 quarters with E. coli and treated at 4, 12, 24, and 36 h postinfection with 300 mg of cefapirin in 1 quarter and a combination of 300 mg of cefapirin and 20mg of prednisolone in another quarter. At 24h (n=3) or 48 h (n=3) postinfection cows were euthanized for tissue sampling. Clinical scores, somatic cell count, and California mastitis test scores, as well as IL-1β, IFN-γ, IL-4, and IL-10 levels and bacterial growth in milk, were measured every 6h. Experimental inoculation caused a moderate clinical mastitis in all cows in challenged, untreated quarters. The E. coli challenge strain was recovered from all infected quarters and confirmed by PCR-based fingerprinting. Challenged, untreated control quarters showed increased concentrations of all measured cytokines together with recruitment of polymorphonuclear neutrophilic leukocytes at 24 and 48 h postchallenge. Both treatments reduced udder swelling and sensitivity with no statistically significant difference between treatment groups. Administration of cefapirin alone or in combination with prednisolone resulted in significantly lower concentrations of IFN-γ, IL-1β, and IL-10 compared with challenged, untreated quarters. Treated quarters did show IL-4 production, but concentrations were significantly decreased compared with untreated, challenged quarters. Quarters treated with the combination of cefapirin and prednisolone showed a significantly lower concentration of IL-4 compared with cefapirin-only treatment. At both 24 and 48 h postinoculation, the level of polymorphonuclear neutrophilic leukocyte recruitment was lowest in challenged quarters treated with a combination of cefapirin and prednisolone, followed by cefapirin alone. Taken together, treatment with cefapirin alone inhibited bacterial growth in milk and reduced the host inflammatory responses. Addition of prednisolone to cefapirin had a synergistic effect, resulting in a lower density of leukocytes in tissue and milk and a quicker restoration of milk quality.
authors.affiliation: Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA. ass233@cornell.edu
authors.forename: Anja
authors.initials: A
authors.lastname: Sipka
authors.forename: Abhijit
authors.initials: A
authors.lastname: Gurjar
authors.forename: Suzanne
authors.initials: S
authors.lastname: Klaessig
authors.forename: Gerald E
authors.initials: GE
authors.lastname: Duhamel
authors.forename: Andrew
authors.initials: A
authors.lastname: Skidmore
authors.forename: Jantijn
authors.initials: J
authors.lastname: Swinkels
authors.forename: Peter
authors.initials: P
authors.lastname: Cox
authors.forename: Ynte
authors.initials: Y
authors.lastname: Schukken
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D002417:Cattle; D002452:Cell Count; D002514:Cephapirin / Q000008:administration & dosage*; D016207:Cytokines / Q000032:analysis; D004357:Drug Synergism; D004359:Drug Therapy, Combination / Q000662:veterinary; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000662:veterinary*; D005260:Female; D007774:Lactation; D008321:Mammary Glands, Animal / Q000503:physiopathology; D008414:Mastitis, Bovine / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D008892:Milk / Q000166:cytology / Q000382:microbiology; D011239:Prednisolone / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D016207:Cytokines; D002514:Cephapirin; D011239:Prednisolone